21st Austria weekly - Croma-Pharma, Valneva, Andritz (13/06/2023)

21st Austria weekly - Croma-Pharma Valneva Andritz 13/06/2023 [pic1]Croma-Pharma: Croma-Pharma® an Austrian based global player in the minimally invasive aesthetics market announced today that June first patient will be enrolled clinical trial1 for approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 China. The randomised multi-centre evaluator blinded parallel group active controlled Phase 3 is being led by Lanhzou Biotechnique Development with intention to confirm efficacy and safety Lidocaine respect mid-facial volume insufficiency and/or profile deficient participants. trial organised executed research organisat…